Inflammation and subsequent genomic mutations in IGF-2R result in IGF-2 over-expression and a reduction in the inhibitory effects of TGF-β signaling, a feature commonly observed early in the development of HCC [53,54]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.